Analyst Research

Report Title Price
Provider: Reuters Investment Profile
$20.00
Provider: GlobalData
$125.00
Provider: GlobalData
$125.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Faes Farma SA Announces Positive Results Of Bilastina Development In Japan In Cooperation With Taiho


Monday, 8 Apr 2013 02:07am EDT 

Faes Farma SA announced that following the signing of the license for Bilastina in Japan in 2012, the Company is undertaking the necessary local clinical development in collaboration with its Japanese partner Taiho (Otsuka group). The first results, recently received, are fully positive. 

Company Quote

1.855
0.02 +1.09%
21 Oct 2014